The Discounted Cash Flow (DCF) valuation of TherapeuticsMD Inc (TXMD) is (1,436.14) USD. With the latest stock price at 2.07 USD, the upside of TherapeuticsMD Inc based on DCF is -69478.6%.
Based on the latest price of 2.07 USD and our DCF valuation, TherapeuticsMD Inc (TXMD) is a sell. selling TXMD stocks now will result in a potential gain of 69478.6%.
Note: valuation result may not be accurate due to the company's negative cashflows.
| Range | Selected | |
| WACC / Discount Rate | 5.5% - 7.4% | 6.4% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (6,686.57) - (811.84) | (1,436.14) |
| Upside | -323122.6% - -39319.1% | -69478.6% |